Arbutus Biopharma Corporation (ABUS) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
ABUS Stock Price Trajectory (2011–2026)
As of March 2, 2026, Arbutus Biopharma Corporation (ABUS) trades at $4.66, representing a +35.1% return over the past year. The stock has delivered a +3.9% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $31.48 on March 13, 2014. From this peak, ABUS has corrected -85.2%, currently trading 16% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers ALNY (+34.9% 1Y), IONS (+144.5% 1Y), and ARWR (+234.6% 1Y), ABUS has underperformed the peer group average. Compare ABUS vs ALNY →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 4.67 | 4.80 | 4.53 | 4.66 | 4 | -0.85% |
| 2026-02-26 | 4.58 | 4.71 | 4.53 | 4.70 | 4 | +2.17% |
| 2026-02-25 | 4.50 | 4.69 | 4.50 | 4.60 | 4 | +3.14% |
| 2026-02-24 | 4.39 | 4.50 | 4.39 | 4.46 | 4 | +1.59% |
| 2026-02-23 | 4.21 | 4.42 | 4.19 | 4.39 | 4 | +2.81% |
| 2026-02-20 | 4.20 | 4.36 | 4.14 | 4.27 | 4 | +0.71% |
| 2026-02-19 | 4.13 | 4.25 | 4.09 | 4.24 | 1.96M | +2.66% |
| 2026-02-18 | 4.25 | 4.30 | 4.07 | 4.13 | 1.62M | +3.74% |
| 2026-02-17 | 4.03 | 4.03 | 3.96 | 3.98 | 12K | +0.03% |
| 2026-02-13 | 4.03 | 4.12 | 3.94 | 3.98 | 1.03M | -0.75% |
| 2026-02-12 | 4.18 | 4.25 | 3.85 | 4.01 | 2.03M | -3.61% |
| 2026-02-11 | 4.18 | 4.25 | 4.03 | 4.16 | 1.37M | 0.00% |
| 2026-02-10 | 4.05 | 4.26 | 3.99 | 4.16 | 3.18M | +2.72% |
| 2026-02-09 | 3.89 | 4.07 | 3.78 | 4.05 | 2.32M | +5.47% |
| 2026-02-06 | 3.84 | 3.90 | 3.67 | 3.84 | 2.56M | +4.63% |
| 2026-02-05 | 3.88 | 3.92 | 3.62 | 3.67 | 1.61M | -5.41% |
| 2026-02-04 | 4.10 | 4.13 | 3.86 | 3.88 | 1.12M | -5.60% |
| 2026-02-03 | 4.40 | 4.42 | 3.87 | 4.11 | 3.26M | -6.38% |
| 2026-02-02 | 4.13 | 4.60 | 3.50 | 4.39 | 5.29M | +6.30% |
| 2026-01-30 | 4.10 | 4.17 | 4.07 | 4.13 | 886K | 0.00% |
| 2026-01-29 | 4.14 | 4.19 | 4.09 | 4.13 | 674K | -0.24% |
| 2026-01-28 | 4.17 | 4.25 | 4.06 | 4.14 | 1.19M | -0.48% |
| 2026-01-27 | 4.05 | 4.19 | 4.05 | 4.16 | 643K | +1.96% |
| 2026-01-26 | 4.05 | 4.14 | 3.99 | 4.08 | 701K | +0.49% |
| 2026-01-24 | 4.15 | 4.22 | 4.06 | 4.06 | 1.12M | 0.00% |
| 2026-01-23 | 4.15 | 4.23 | 4.06 | 4.06 | 1.14M | -2.40% |
| 2026-01-22 | 4.14 | 4.23 | 4.08 | 4.16 | 834K | +0.48% |
| 2026-01-21 | 4.20 | 4.33 | 4.07 | 4.14 | 1.29M | -1.66% |
| 2026-01-20 | 3.93 | 4.24 | 3.92 | 4.21 | 2.57M | +3.69% |
| 2026-01-16 | 3.94 | 4.20 | 3.68 | 4.06 | 8.52M | -13.62% |
See ABUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABUS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ABUS vs AGIO
See how ABUS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has ABUS stock performed recently?
ABUS returned +35.1% over the past year, beating its 5-year annualized CAGR of +3.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ABUS's all-time high price?
Arbutus Biopharma Corporation reached $31.48 on 2014-03-13. The 52-week high is $5.10. Current 1-year return of +35.1% places the stock closer to historical peaks.
Where can I download ABUS historical price data?
This page provides ABUS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.